Chiara Pierantoni

2.0k total citations
40 papers, 1.3k citations indexed

About

Chiara Pierantoni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Chiara Pierantoni has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Chiara Pierantoni's work include Colorectal Cancer Treatments and Studies (19 papers), Cancer Treatment and Pharmacology (10 papers) and HER2/EGFR in Cancer Research (7 papers). Chiara Pierantoni is often cited by papers focused on Colorectal Cancer Treatments and Studies (19 papers), Cancer Treatment and Pharmacology (10 papers) and HER2/EGFR in Cancer Research (7 papers). Chiara Pierantoni collaborates with scholars based in Italy and Switzerland. Chiara Pierantoni's co-authors include Rossana Berardi, Stefano Cascinu, Mario Scartozzi, Riccardo Giampieri, Gennaro Galizia, Silvia Chiorrini, Alberto Zaniboni, Italo Bearzi, Alessandra Mandolesi and Alfredo Falcone and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Chiara Pierantoni

38 papers receiving 1.2k citations

Peers

Chiara Pierantoni
Yasuo Ejima Japan
Roberto Carmagnani Pestana United States
Elena De Mattia Italy
Daniela Kandioler Austria
Blair Marshall United States
Olaf Christensen United States
Jessica Read United Kingdom
Marianne Krahn Canada
Marine Gilabert France
Jan Cosaert United States
Yasuo Ejima Japan
Chiara Pierantoni
Citations per year, relative to Chiara Pierantoni Chiara Pierantoni (= 1×) peers Yasuo Ejima

Countries citing papers authored by Chiara Pierantoni

Since Specialization
Citations

This map shows the geographic impact of Chiara Pierantoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Pierantoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Pierantoni more than expected).

Fields of papers citing papers by Chiara Pierantoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Pierantoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Pierantoni. The network helps show where Chiara Pierantoni may publish in the future.

Co-authorship network of co-authors of Chiara Pierantoni

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Pierantoni. A scholar is included among the top collaborators of Chiara Pierantoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Pierantoni. Chiara Pierantoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pierantoni, Chiara, et al.. (2024). Molecular Pathways of Colorectal Cancer Development: Mechanisms of Action and Evolution of Main Systemic Therapy Compunds. Digestive Diseases. 42(4). 319–324. 12 indexed citations
2.
Buttitta, Francesco, Chiara Pierantoni, Clarissa Ferrari, et al.. (2021). Chromoendoscopy Is Not Superior to White Light Endoscopy in Improving Adenoma Detection in Lynch Syndrome Cohort Undergoing Surveillance with High-Resolution Colonoscopy: A Real-World Evidence Study. Digestive Diseases. 40(4). 517–525. 4 indexed citations
3.
Tassone, Laura, Mariangela Torniai, Chiara Pierantoni, et al.. (2021). Seminoma Retroperitoneal Relapse 23 Years After Surgery. Oncology and Therapy. 9(1). 239–245. 2 indexed citations
4.
Mandolesi, Daniele, Chiara Pierantoni, Davide Festi, et al.. (2017). Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: Predictive factors. Digestive and Liver Disease. 49(10). 1128–1132. 2 indexed citations
5.
Fuccio, Lorenzo, Daniele Mandolesi, Andrea Farioli, et al.. (2017). Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies. Radiotherapy and Oncology. 122(3). 332–339. 45 indexed citations
6.
Catania, Chiara, Michela Maur, Rossana Berardi, et al.. (2015). The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer. Cell Adhesion & Migration. 9(1-2). 14–21. 52 indexed citations
7.
Berardi, Rossana, Silvia Rinaldi, Daniele Santini, et al.. (2014). Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. Supportive Care in Cancer. 23(5). 1295–1302. 10 indexed citations
8.
Berardi, Rossana, Federico Mocchegiani, Chiara Pierantoni, et al.. (2012). Resected biliary tract cancers: A novel clinical–pathological score correlates with global outcome. Digestive and Liver Disease. 45(1). 70–74. 9 indexed citations
9.
Scartozzi, Mario, Cristian Loretelli, Rossana Berardi, et al.. (2011). Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. Digestive and Liver Disease. 44(1). 74–79. 3 indexed citations
10.
Scartozzi, Mario, Alessandra Mandolesi, Riccardo Giampieri, et al.. (2010). Insulin‐like growth factor 1 expression correlates with clinical outcome in K‐RAS wild type colorectal cancer patients treated with cetuximab and irinotecan. International Journal of Cancer. 127(8). 1941–1947. 64 indexed citations
11.
Scartozzi, Mario, Gianluca Svegliati‐Baroni, Luca Faloppi, et al.. (2010). Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis. Journal of Experimental & Clinical Cancer Research. 29(1). 164–164. 40 indexed citations
12.
Berardi, Rossana, Elena Maccaroni, Azzurra Onofri, et al.. (2009). Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1. Expert Opinion on Pharmacotherapy. 10(14). 2245–2258. 8 indexed citations
13.
14.
Scartozzi, Mario, Gennaro Galizia, Silvia Chiorrini, et al.. (2008). Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab. Annals of Oncology. 20(2). 227–230. 261 indexed citations
15.
Cascinu, Stefano, Rossana Berardi, Roberto Labianca, et al.. (2008). Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial. The Lancet Oncology. 9(1). 39–44. 108 indexed citations
16.
Pierantoni, Chiara, et al.. (2008). Pancreatic cancer: Progress in cancer therapy. Critical Reviews in Oncology/Hematology. 67(1). 27–38. 29 indexed citations
17.
Scartozzi, Mario, Italo Bearzi, Rossana Berardi, et al.. (2007). Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options. British Journal of Cancer. 97(1). 92–97. 35 indexed citations
18.
Cascinu, Stefano, Mario Scartozzi, Chiara Pierantoni, et al.. (2007). COX-2 and NF-KB Overexpression Is Common in Pancreatic Cancer but Does Not Predict for COX-2 Inhibitors Activity in Combination With Gemcitabine and Oxaliplatin. American Journal of Clinical Oncology. 30(5). 526–530. 29 indexed citations
19.
Scartozzi, Mario, et al.. (2006). Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice. Expert Opinion on Therapeutic Targets. 10(2). 281–287. 2 indexed citations
20.
Scartozzi, Mario, Alfredo Falcone, Francesca Pucci, et al.. (2006). Capecitabine and Mitomycin c May be an Effective Treatment Option for Third-line Chemotherapy in Advanced Colorectal Cancer. Tumori Journal. 92(5). 384–388. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuo Ejima Breakdown of academic impact, for papers by Roberto Carmagnani Pestana Breakdown of academic impact, for papers by Elena De Mattia Breakdown of academic impact, for papers by Daniela Kandioler Breakdown of academic impact, for papers by Blair Marshall Breakdown of academic impact, for papers by Olaf Christensen Breakdown of academic impact, for papers by Jessica Read Breakdown of academic impact, for papers by Marianne Krahn Breakdown of academic impact, for papers by Marine Gilabert Breakdown of academic impact, for papers by Jan Cosaert
Rankless by CCL
2026